{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:45:26Z","timestamp":1773297926983,"version":"3.50.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.drugpo.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T02:01:16Z","timestamp":1486605676000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Building smart cannabis policy from the science up"],"prefix":"10.1016","volume":"42","author":[{"given":"Susan R.B.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia D.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben D.","family":"Baler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.drugpo.2017.01.007_bib0005","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1113\/jphysiol.2011.220855","article-title":"Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): What we still do not know","volume":"590","author":"Alger","year":"2012","journal-title":"The Journal of Physiology"},{"issue":"8574","key":"10.1016\/j.drugpo.2017.01.007_bib0010","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"330","author":"Andr\u00e9asson","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0015","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0020","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ (Clinical Research Edition)"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0025","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1124\/mol.112.080879","article-title":"CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity","volume":"83","author":"Baillie","year":"2013","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0030","doi-asserted-by":"publisher","first-page":"e55821","DOI":"10.1371\/journal.pone.0055821","article-title":"Structural and functional imaging studies in chronic cannabis users: A systematic review of adolescent and adult findings","volume":"8","author":"Batalla","year":"2013","journal-title":"PLoS One"},{"issue":"April(1\u20132)","key":"10.1016\/j.drugpo.2017.01.007_bib0035","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: A review of their therapeutic potential","volume":"105","author":"Ben Amar","year":"2006","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0040","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0045","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0050","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0055","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0060","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<9::AID-HEC471>3.0.CO;2-Z","article-title":"The relationship between marijuana initiation and dropping out of high school","volume":"9","author":"Bray","year":"2000","journal-title":"Health Economics"},{"issue":"7","key":"10.1016\/j.drugpo.2017.01.007_bib0065","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition\u2014A systematic review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0070","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.yco.0000218592.00689.e5","article-title":"The cannabis withdrawal syndrome","volume":"19","author":"Budney","year":"2006","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0075","first-page":"111","article-title":"The adolescent brain","volume":"1124","author":"Casey","year":"2008","journal-title":"The Year in Cognitive Neuroscience"},{"issue":"10","key":"10.1016\/j.drugpo.2017.01.007_bib0080","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0085","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addiction Biology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0090","series-title":"Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Pulication No. SMA 15-4927, NSDUH Series H-50","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"issue":"20","key":"10.1016\/j.drugpo.2017.01.007_bib0095","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/psb.684","article-title":"Sativex: Oromucosal cannabinoid spray for spasticity in MS","volume":"21","author":"Chaplin","year":"2010","journal-title":"Prescriber"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0100","series-title":"Adolescent brain cognitive development study","author":"Collaborative Research on Addiction at the National Institutes of Health","year":"2016"},{"issue":"July(1)","key":"10.1016\/j.drugpo.2017.01.007_bib0105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.pnpbp.2012.02.009","article-title":"Cannabinoid receptors: Nomenclature and pharmacological principles","volume":"38","author":"Console-Bram","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0110","series-title":"Cannabinoids in Tourette\u2019s syndrome. Cochrane database of systematic reviews","author":"Curtis","year":"2009"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0115","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0892-0362(94)90114-7","article-title":"Effect of prenatal marijuana exposure on the cognitive development of offspring at age three","volume":"16","author":"Day","year":"1994","journal-title":"Neurotoxicology and Teratology"},{"issue":"10","key":"10.1016\/j.drugpo.2017.01.007_bib0120","doi-asserted-by":"publisher","first-page":"e76635","DOI":"10.1371\/journal.pone.0076635","article-title":"The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 Study","volume":"8","author":"Degenhardt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0125","first-page":"1","article-title":"Marijuana use in epilepsy: The myth and the reality","volume":"15:65","author":"Detyniecki","year":"2015","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"5","key":"10.1016\/j.drugpo.2017.01.007_bib0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0135","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0140","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: An open-label interventional trial","volume":"15","author":"Devinsky","year":"2015","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0145","article-title":"Efficacy and safety of epidiolex (cannabidiol) in children and young adults with treatment-resistant epilepsy: Initial data from an expanded access program","author":"Devinsky","year":"2015","journal-title":"American Epilepsy Society: Annual Meeting"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0150","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0155","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/phr\/114.1.14","article-title":"Drug prohibition and public health: 25 years of evidence","volume":"114","author":"Drucker","year":"1999","journal-title":"Public Health Reports"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0160","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08897070802218166","article-title":"Marijuana neurobiology and treatment","volume":"29","author":"Elkashef","year":"2008","journal-title":"Substance Abuse"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0165","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.npp.1301127","article-title":"Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats","volume":"32","author":"Ellgren","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.drugpo.2017.01.007_bib0170","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995\u20132014): Analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0175","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugalcdep.2015.02.014","article-title":"Cannabis problem experiences among users of the tobacco\u2013cannabis combination known as blunts","volume":"150","author":"Fairman","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0180","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1360-0443.2008.02221.x","article-title":"Cannabis use and later life outcomes","volume":"103","author":"Fergusson","year":"2008","journal-title":"Addiction"},{"issue":"47","key":"10.1016\/j.drugpo.2017.01.007_bib0185","doi-asserted-by":"publisher","first-page":"16913","DOI":"10.1073\/pnas.1415297111","article-title":"Long-term effects of marijuana use on the brain","volume":"111","author":"Filbey","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0190","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(93)90468-W","article-title":"Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent","volume":"231","author":"Fride","year":"1993","journal-title":"European Journal of Pharmacology"},{"issue":"23\u201324","key":"10.1016\/j.drugpo.2017.01.007_bib0195","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/0024-3205(95)00203-I","article-title":"The Ottawa Prenatal Prospective Study (OPPS): Methodological issues and findings\u2014it\u2019s easy to throw the baby out with the bath water","volume":"56","author":"Fried","year":"1995","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.drugpo.2017.01.007_bib0200","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"Journal of the American Chemical Society"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0205","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1017\/S0033291714001524","article-title":"The association between cannabis abuse and subsequent schizophrenia: A Swedish national co-relative control study","volume":"45","author":"Giordano","year":"2015","journal-title":"Psychological Medicine"},{"issue":"21","key":"10.1016\/j.drugpo.2017.01.007_bib0210","doi-asserted-by":"publisher","first-page":"8174","DOI":"10.1073\/pnas.0402680101","article-title":"Dynamic mapping of human cortical development during childhood through early adulthood","volume":"101","author":"Gogtay","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0215","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugpo.2006.10.001","article-title":"Do medical cannabis laws encourage cannabis use?","volume":"18","author":"Gorman","year":"2007","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0220","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addbeh.2009.08.006","article-title":"A cotwin-control analysis of drug use and abuse\/dependence risk associated with early-onset cannabis use","volume":"35","author":"Grant","year":"2010","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0225","series-title":"Drug decriminalization in Portugal: Lessons For Creating Fair and Successful Drug Policies","author":"Greenwald","year":"2009"},{"issue":"29\u201330","key":"10.1016\/j.drugpo.2017.01.007_bib0230","first-page":"495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0235","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1360-0443.2007.01745.x","article-title":"Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys","volume":"102","author":"Grucza","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0240","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamapsychiatry.2015.3111","article-title":"Recent trends in the prevalence of marijuana use and associated disorders in the United States","volume":"73","author":"Grucza","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"November(11)","key":"10.1016\/j.drugpo.2017.01.007_bib0245","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: Mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0250","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/add.12703","article-title":"What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?","volume":"110","author":"Hall","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0255","article-title":"The health and social effects of nonmedical cannabis use","year":"2016"},{"issue":"14","key":"10.1016\/j.drugpo.2017.01.007_bib0260","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.drugpo.2017.01.007_bib0265","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001\u20132002 and 2012\u20132013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.drugpo.2017.01.007_bib0270","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S2215-0366(15)00217-5","article-title":"Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys","volume":"2","author":"Hasin","year":"2015","journal-title":"The Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.drugpo.2017.01.007_bib0275","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0280","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/j.drugpo.2017.01.007_bib0285","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012237","article-title":"Synaptic targets of delta9-tetrahydrocannabinol in the central nervous system","volume":"3","author":"Hoffman","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0290","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/00952990.2013.837914","article-title":"Functional connectivity and cannabis use in high-risk adolescents","volume":"39","author":"Houck","year":"2013","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"Part B","key":"10.1016\/j.drugpo.2017.01.007_bib0295","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuropharm.2013.07.028","article-title":"Trajectory of adolescent cannabis use on addiction vulnerability","volume":"76","author":"Hurd","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5\u20136","key":"10.1016\/j.drugpo.2017.01.007_bib0300","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behavioural Pharmacology"},{"issue":"5","key":"10.1016\/j.drugpo.2017.01.007_bib0305","doi-asserted-by":"publisher","first-page":"E500","DOI":"10.1073\/pnas.1516648113","article-title":"Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies","volume":"113","author":"Jackson","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"10.1016\/j.drugpo.2017.01.007_bib0310","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.2174\/13816128113199990426","article-title":"Effects of cannabis on the adolescent brain","volume":"20","author":"Jacobus","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0315","unstructured":"Johnston, L. D., O\u2019Malley P. M., Miech R. A., Bachman J. G., Schulenberg J. E. (2016). Monitoring the Future national survey results on drug use, 1975-2015: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan. Institute for Social Research The University of Michigan Ann Arbor, Michigan Printed February 2016."},{"issue":"4217","key":"10.1016\/j.drugpo.2017.01.007_bib0320","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1126\/science.1188374","article-title":"Stages in adolescent involvement in drug use","volume":"190","author":"Kandel","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0325","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF01538684","article-title":"Antecedents of adolescent initiation into stages of drug use: A developmental analysis","volume":"7","author":"Kandel","year":"1978","journal-title":"Journal of Youth and Adolescence"},{"issue":"December(12)","key":"10.1016\/j.drugpo.2017.01.007_bib0330","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/add.13523","article-title":"How does state marijuana policy affect U. S. youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991\u20132014","volume":"111","author":"Keyes","year":"2016","journal-title":"Addiction"},{"issue":"17","key":"10.1016\/j.drugpo.2017.01.007_bib0335","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0340","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: A systematic meta-analysis","volume":"68","author":"Large","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0345","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.01.007_bib0350","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"115","author":"Lopez-Quintero","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.drugpo.2017.01.007_bib0355","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2105\/AJPH.2012.301117","article-title":"Effects of state medical marijuana laws on adolescent marijuana use","volume":"103","author":"Lynne-Landsman","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.drugpo.2017.01.007_bib0360","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1046\/j.1360-0443.2000.951116213.x","article-title":"The effects of adolescent cannabis use on educational attainment: a review","volume":"95","author":"Lynskey","year":"2000","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2017.01.007_bib0365","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1360-0443.2003.00356.x","article-title":"A longitudinal study of the effects of adolescent cannabis use on high school completion","volume":"98","author":"Lynskey","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0370","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jama.289.4.427","article-title":"Escalation of drug use in early-onset cannabis users vs co-twin controls","volume":"289","author":"Lynskey","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0375","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10519-005-9023-x","article-title":"Early onset cannabis use and progression to other drug use in a sample of dutch twins","volume":"36","author":"Lynskey","year":"2006","journal-title":"Behavior Genetics"},{"issue":"12","key":"10.1016\/j.drugpo.2017.01.007_bib0380","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: From physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nature Reviews Neuroscience"},{"issue":"11","key":"10.1016\/j.drugpo.2017.01.007_bib0385","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1360-0443.2011.03572.x","article-title":"What can we learn from the Dutch cannabis coffeeshop system?","volume":"106","author":"MacCoun","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0390","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: Where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0395","series-title":"Update of cannabis and its medical use","author":"Madras","year":"2015"},{"issue":"October(5)","key":"10.1016\/j.drugpo.2017.01.007_bib0400","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.smim.2014.04.002","article-title":"What we know and do not know about the cannabinoid receptor 2 (CB2)","volume":"26","author":"Malfitano","year":"2014","journal-title":"Seminars in Immunology"},{"issue":"9","key":"10.1016\/j.drugpo.2017.01.007_bib0405","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137034","article-title":"Potential therapeutic value of a novel FAAH inhibitor for the treatment of anxiety","volume":"10","author":"Marco","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.drugpo.2017.01.007_bib0410","first-page":"1","article-title":"Prenatal cannabis and tobacco exposure in relation to brain morphology: A prospective neuroimaging study in young children","volume":"79","author":"Marroun","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0415","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000320550","article-title":"Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: The generation R study","volume":"17","author":"Marroun","year":"2010","journal-title":"European Addiction Research"},{"issue":"11","key":"10.1016\/j.drugpo.2017.01.007_bib0420","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/hec.1561","article-title":"Marijuana use and high school dropout: The influence of unobservables","volume":"19","author":"McCaffrey","year":"2010","journal-title":"Health Economics"},{"issue":"January(1)","key":"10.1016\/j.drugpo.2017.01.007_bib0425","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.drugpo.2009.09.001","article-title":"Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies","volume":"21","author":"McLaren","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.01.007_bib0430","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00184-5","article-title":"A historical overview of chemical research on cannabinoids","volume":"108","author":"Mechoulam","year":"2000","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0435","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"Journal of Clinical Pharmacology"},{"issue":"40","key":"10.1016\/j.drugpo.2017.01.007_bib0440","doi-asserted-by":"publisher","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"Meier","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0445","doi-asserted-by":"crossref","DOI":"10.1111\/j.1465-3362.2009.00132.x","article-title":"An overview of systematic reviews on cannabis and psychosis: Discussing apparently conflicting results","author":"Minozzi","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"9584","key":"10.1016\/j.drugpo.2017.01.007_bib0450","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0455","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1089\/can.2015.0005","article-title":"Allosteric modulators of the CB1 cannabinoid receptor: A structural update review","volume":"1","author":"Morales","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0460","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00280.x","article-title":"Reassessing the marijuana gateway effect","author":"Morral","year":"2002","journal-title":"Addiction"},{"issue":"6441","key":"10.1016\/j.drugpo.2017.01.007_bib0465","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0470","series-title":"State medical marijuana laws","author":"National Conference of State Legislatures","year":"2016"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0475","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease\u2014Successes and failures","author":"Pacher","year":"2013","journal-title":"FEBS Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0480","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pam.21804","article-title":"Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details","volume":"34","author":"Pacula","year":"2014","journal-title":"Journal of Policy Analysis and Management"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0485","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1586\/14737175.2016.1121098","article-title":"Cannabidiol as potential treatment in refractory pediatric epilepsy","volume":"16","author":"Paolino","year":"2016","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"June(2)","key":"10.1016\/j.drugpo.2017.01.007_bib0490","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: From THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addiction Biology"},{"issue":"1607","key":"10.1016\/j.drugpo.2017.01.007_bib0495","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"11","key":"10.1016\/j.drugpo.2017.01.007_bib0500","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0505","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2006.00021.x","article-title":"Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)","author":"Piomelli","year":"2006","journal-title":"CNS Drug Reviews"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0510","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0376-8716(02)00334-4","article-title":"Early-onset cannabis use and cognitive deficits: What is the nature of the association?","volume":"69","author":"Pope","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"11 Suppl","key":"10.1016\/j.drugpo.2017.01.007_bib0515","doi-asserted-by":"publisher","first-page":"41S","DOI":"10.1002\/j.1552-4604.2002.tb06002.x","article-title":"Cognitive measures in long-term cannabis users","volume":"42","author":"Pope","year":"2002","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0520","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2013.11.014","article-title":"A controlled family study of cannabis users with and without psychosis","volume":"152","author":"Proal","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0525","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: A systematic review of the evidence","volume":"9","author":"Prud\u2019homme","year":"2015","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0530","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpsyt.2014.00054","article-title":"Gone to pot\u2014A review of the association between cannabis and psychosis","volume":"5","author":"Radhakrishnan","year":"2014","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0535","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pbb.2011.02.024","article-title":"Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects","volume":"98","author":"Rahn","year":"2011","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0540","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0892-0362(02)00193-9","article-title":"Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years","volume":"24","author":"Richardson","year":"2002","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0545","doi-asserted-by":"publisher","DOI":"10.3390\/ph3082517","article-title":"Brain CB2 receptors: Implications for neuropsychiatric disorders","author":"Roche","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0550","volume":"Vol. 3","author":"Rocky Mountains High Intensity Drug Trafficking Area","year":"2015"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0555","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13181-011-0202-2","article-title":"Here today, gone tomorrow and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines","volume":"8","author":"Rosenbaum","year":"2012","journal-title":"Journal of Medical Toxicology"},{"issue":"7","key":"10.1016\/j.drugpo.2017.01.007_bib0560","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaac.2012.04.004","article-title":"Medical marijuana use among adolescents in substance abuse treatment","volume":"51","author":"Salomonsen-Sautel","year":"2012","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1016\/j.drugpo.2017.01.007_bib0565","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/ern.11.47","article-title":"THC and CBD oromucosal spray (Sativex\u00ae) in the management of spasticity associated with multiple sclerosis","volume":"11","author":"Sastre-Garriga","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0570","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0575","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2215-0366(14)70307-4","article-title":"Young adult sequelae of adolescent cannabis use: An integrative analysis","volume":"1","author":"Silins","year":"2014","journal-title":"The Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.01.007_bib0580","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/schbul\/sbt176","article-title":"Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects","volume":"40","author":"Smith","year":"2014","journal-title":"Schizophrenia Bulletin"},{"issue":"9","key":"10.1016\/j.drugpo.2017.01.007_bib0585","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","article-title":"Cognitive functioning of long-term heavy cannabis users seeking treatment","volume":"287","author":"Solowij","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.drugpo.2017.01.007_bib0590","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jamapsychiatry.2016.1329","article-title":"Effects of cannabis use on human behavior: A call for standardization of cannabis use metrics","volume":"73","author":"Solowij","year":"2016","journal-title":"JAMA Psychiatry, E1"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0595","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.biopsych.2006.03.073","article-title":"Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood","volume":"61","author":"Spano","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"February(2)","key":"10.1016\/j.drugpo.2017.01.007_bib0600","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jadohealth.2012.05.006","article-title":"Adolescent neurodevelopment","volume":"52","author":"Spear","year":"2013","journal-title":"Journal of Adolescent Health"},{"issue":"10","key":"10.1016\/j.drugpo.2017.01.007_bib0605","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1017\/S0033291706008361","article-title":"Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity","volume":"36","author":"Stinson","year":"2006","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0610","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2015.05.018","article-title":"The effect of medical cannabis laws on juvenile cannabis use","volume":"27","author":"Stolzenberg","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0615","unstructured":"Substance Abuse and Mental Health Services Administration (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration."},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0620","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0625","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/npp.2013.352","article-title":"Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation","volume":"39","author":"Szutorisz","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.drugpo.2017.01.007_bib0630","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: An overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0635","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1709","article-title":"Nabilone for the management of pain","author":"Tsang","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0640","series-title":"The FDA\u2019s drug review process: Ensuring drugs are safe and effective","author":"U.S. Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0645","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mp.2015.118","article-title":"Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium","volume":"21","author":"Van Erp","year":"2016","journal-title":"Molecular Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2017.01.007_bib0650","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of \u03949-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0655","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.schres.2014.07.017","article-title":"Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia","volume":"159","author":"Volk","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0660","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2017.01.007_bib0665","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugpo.2017.01.007_bib0670","series-title":"Uruguay\u2019s drug policy: Major innovations, major challenges. Improving global drug policy: Comparative perspectives and UNGASS 2016","author":"Walsh","year":"2016"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0675","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1523\/JNEUROSCI.2946-14.2015","article-title":"Daily marijuana use is not associated with brain morphometric measures in adolescents or adults","volume":"35","author":"Weiland","year":"2015","journal-title":"The Journal of Neuroscience"},{"issue":"24","key":"10.1016\/j.drugpo.2017.01.007_bib0680","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.drugpo.2017.01.007_bib0685","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR","volume":"52","author":"Wong","year":"2010","journal-title":"NeuroImage"},{"issue":"9","key":"10.1016\/j.drugpo.2017.01.007_bib0690","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB2 receptors modulate cocaine\u2019s actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/j.drugpo.2017.01.007_bib0695","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","article-title":"Regional brain abnormalities associated with long-term heavy cannabis use","volume":"65","author":"Y\u00fccel","year":"2008","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1016\/j.drugpo.2017.01.007_bib0700","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/aws136","article-title":"Effect of long-term cannabis use on axonal fibre connectivity","volume":"135","author":"Zalesky","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.drugpo.2017.01.007_bib0705","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1756285615612659","article-title":"Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis","volume":"9","author":"Zettl","year":"2016","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"32","key":"10.1016\/j.drugpo.2017.01.007_bib0710","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation","volume":"18","author":"Zuardi","year":"2012","journal-title":"Current Pharmaceutical Design"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:22:20Z","timestamp":1749961340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917300099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":142,"alternative-id":["S0955395917300099"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.01.007","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Building smart cannabis policy from the science up","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}